preexist immune human adenoviru serotyp ad common genre popup bypass could maxim vaccine efficacy vaccine intramuscular im nasal oral po rout express ebola air glycoprotein adage full protect naïv mouse lethal challenge present vaccine survive frequency inγ cd cell reduce anim rout respect neutral antibody detect serum either treatment group compromise v pei antiebola antibody nab reciprocal dilute group number infγ bronchioalveolar lava fluid bal immune compromise sfcmillion mnc howe level improv immune response abbas legal given modify survive day administer peg unmodified legal increase fold result provide insight degree b cell media necessary protect virus suggest modify caps influence type elicit 